Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Donepezil Extension in Migraine Prophylaxis
NCT01146509Phase 2Completed
- Sponsor
- Eisai Co., Ltd.
- Start
- Jan 2003
- Primary completion
- Apr 2004
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 2, open-label, single-arm trial of donepezil in migraine, sponsored by Eisai Co., Ltd. Primary endpoint: Safety evaluation up to 52 weeks. Started Jan 2003; status: completed.
02
Drugs
donepezil
03
Conditions
migraine
Beyond the preview
Go deeper on NCT01146509.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01146509.